To investigate the effects of postoperative surgical treatment of infantile adenoidal hypertrophy on children, the recurrence rate, and the changes in immune levels before and after surgery. Low temperature plasma ablation was performed in 11 infants with adenoidal hypertrophy to evaluate the risk of postoperative anesthesia and the effect of surgery on recurrence rate and immunity. During the follow-up period of 3 to 6 months, 2 patients had recurrence(18.18%), including 1 case with round pillow hyperplasia and 1 case with tonsil reactive hyperplasia. Three months after surgery, the immune level did not decrease significantly compared with that before surgery. No serious complications occurred in all children. Infants with adenoidal hypertrophy fall asleep, snoring, open mouth breathing, and belching seriously affect the quality of sleep and growth. Children who have been ineffective for more than 2 months undergo low-temperature plasma ablation. General anesthesia is safer. After that, the sleep quality of the children was significantly improved, and the immunity did not decrease significantly. Low temperature plasma ablation in infants with adenoidal hypertrophy is safe and effective, but it is not a routine treatment. Clinical symptoms are easy to repeat. The indications for surgery should be appropriately weighed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128551 | PMC |
http://dx.doi.org/10.13201/j.issn.2096-7993.2021.01.010 | DOI Listing |
Eur Arch Otorhinolaryngol
January 2025
Department of Otolaryngology Head and Neck Surgery, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
Objective: This study aims to explore the clinical effects of simultaneous balloon eustachian tuboplasty (BET) in treating chronic secretory otitis media (COME) in children with bilateral tonsil and adenoid hypertrophy (TAH), providing a theoretical basis for the clinical application of BET.
Methods: From January 2023 to January 2024, 30 children diagnosed with COME and bilateral TAH were included in this retrospective study at our hospital. The cohort comprised a total of 55 affected ears.
Radiol Case Rep
March 2025
Department of Otorhinolaryngology Head and Neck Surgery, Charles Nicolle Hospital, Tunis, Tunisia.
Tracheal adenoid cystic carcinoma is a rare malignancy. We report the case of a 65-year-old male who presented to our department due to a 3-month history of mild dysphagia without other associated symptoms. The neck, laryngeal, and hypopharyngeal examinations were normal.
View Article and Find Full Text PDFNat Sci Sleep
December 2024
Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430000, People's Republic of China.
Purpose: This study aims to develop a deep learning methodology for quantitative assessing adenoid hypertrophy in nasopharyngoscopy images and to investigate its correlation with the apnea-hypopnea index (AHI) in pediatric patients with obstructive sleep apnea (OSA).
Patients And Methods: A total of 1642 nasopharyngoscopy images were collected from pediatric patients aged 3 to 12 years. After excluding images with obscured secretions, incomplete adenoid exposure, 1500 images were retained for analysis.
Front Public Health
December 2024
The First People's Hospital of Lianyungang, Lianyungang, China.
Adenoid hypertrophy (AH) is characterized by pathological hyperplasia of the nasopharyngeal tonsils, a component of Waldryer's ring, which represents the first immune defense of the upper respiratory tract. The pathogenic factors contributing to AH remain to be comprehensively investigated to date. Although some studies suggest that environmental exposure to smoke and allergens, respiratory tract infections, and hormonal influences likely contribute to the development of AH, further research is necessary for fully elucidating the effects of these factors on the onset and progression of AH.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!